multiple endocrine neoplasia type-2 (MEN-2)

From Aaushi
Jump to navigation Jump to search

Introduction

Uncommon inherited cancer syndrome.

Pathology

Genetics

Clinical manifestations

Laboratory

Management

More general terms

More specific terms

Additional terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 270-71
  2. Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 16, 18. American College of Physicians, Philadelphia 1998, 2006, 2012, 2018.
  3. Brandi ML, Gagel RF, Angeli A, Bilezikian JP Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11739416
  4. Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview. Genet Med. 2011 Sep;13(9):755-64 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21552134
  5. Krampitz GW, Norton JA RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer. 2014 Jul 1;120(13):1920-31. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24699901 Free Article
  6. 6.0 6.1 ARUP Consult: Multiple Endocrine Neoplasia Type 2 https://arupconsult.com/ati/multiple-endocrine-neoplasia-type-2
  7. 7.0 7.1 NEJM Knowledge+ Endocrinology

Patient information

multiple endocrine neoplasia type-2 patient information

Database